Geneticists have a better understanding of how prehistoric pairings unfolded, with new research suggesting they were mostly ...
As of Friday, February 27, Fulgent Genetics, Inc.’s FLGT share price has dipped by 31.34%, which has investors questioning if this is right time to buy.
A study shows that interbreeding between the two species occurred primarily in one direction, and the origin of this bias is ...
Opus Genetics targets inherited retinal diseases with one-dose AAV gene augmentations. Read why IRD stock is a Buy.
Scientists have identified how specific genetic changes function in cells to influence disease risk and other human health ...
Sentinel participant showed OPGx-BEST1 was well tolerated with no ocular inflammation, treatment-related adverse events, or ...
Myriad Genetics (NASDAQ:MYGN) executives highlighted fourth quarter and full-year 2025 results alongside a slate of planned ...
Duckweed is the fastest-growing flowering plant, but new knowledge of duckweed genetics discovered by Adelaide University researchers could lead to even faster growing rates. The research team, led by ...
Myriad Genetics delivered a solid Q4 2025 earnings beat, with positive adjusted EPS and strong test volume growth. Click for ...
Myriad Genetics (MYGN) surged 24% in premarket trading on Tuesday after reporting a quarterly earnings beat and outlining a 2026 revenue target of $860 million to $880 million while highlighting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results